-
Signant Health Unveils its full Conference Line-up for SCOPE 2020
Feb 11, 2020, 12:02 PM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Feb 11, 2020 - The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyondFull story -
AbbVie’s Fresh Look At How AI And Quantum Computing Will Transform Biotech
Feb 11, 2020, 06:20 AM by Michael CroftFull storyBio-IT World | AbbVie's head of artificial intelligence and senior principal data scientist within the R&D Information Research group argues our innovations must produce value, operational first, then analytic, and finally experiential.
-
Olaris Announces Grant from The Michael J. Fox Foundation for Parkinson’s Research
Feb 10, 2020, 15:50 PM by Michael CroftWALTHAM, MA, UNITED STATES - Feb 11, 2020 - Olaris, a precision medicine company that is fundamentally changing how diseases are diagnosed and treated, today announced it has received a grant from The Michael JFull story -
Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film
Feb 10, 2020, 15:17 PM by Michael CroftWARREN, NJ - Feb 10, 2020 - Aquestive Therapeutics, Inc. (AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems, announced today that, as anticipated, the UFull story -
Efficient digital documentation of microscopic samples
Feb 10, 2020, 14:29 PM by Michael CroftJENA, GERMANY - Feb 10, 2020 - Smart Microscopy from ZEISS is a new concept for the routine digital documentation of microscopic samplesFull story -
Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research
Feb 10, 2020, 08:39 AM by Michael CroftPRINCETON, NJ - Feb 10, 2020 - Certara®, the global model-informed drug development and decision support leader, today announced that its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sourcesFull story -
Scaling Precision Oncology
Feb 7, 2020, 10:05 AM by Michael CroftFull storyBio-IT World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.
-
Nature Begins Publishing Peer Reviews
Feb 6, 2020, 12:50 PM by Michael CroftFull storyBio-IT World | Nature Research announced yesterday that its flagship publication, Nature, will join others in the family in publishing peer review correspondence.
-
How Wearables Will Help Us Keep Tabs On The Future Of Health
Feb 6, 2020, 12:00 PM by Michael CroftFull storyBio-IT World | In 2012, Michael Snyder created an integrative personal omics profile, an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual. Today, Snyder is incorporating data from smart watches, continuous glucose monitoring, and other wearables to track people’s health and find early signs of disease.
-
Summit Healthcare to Showcase Robotic Process Automation (RPA) Technology and Services at HIMSS20
Feb 6, 2020, 08:37 AM by Michael CroftBRAINTREE, MA - Feb 6, 2020 - Braintree, Mass., February 6, 2020 - Summit Healthcare, a leading provider of automation and healthcare systems integration technology, today announced that it will be showcasing cutting-edge Robotic Process Automation (RPA) solutions in booth #5558 at the 2020 HIMSS Global Health Conference & Exhibition, which will be held in Orlando, FL, between March 9 and March 13, 2020Full story -
Data Storage and Transport: Headaches and Possible Remedies
Feb 5, 2020, 10:10 AM by Michael CroftBio-IT World | As organizations generate ever-growing amounts of data, finding ways to overcome the related difficulties of storing, moving, and managing that flood of information remains a central issue.Full story -
Understanding the immune system in Chronic Immune-Mediated inflammatory diseases
Feb 5, 2020, 06:56 AM by Michael CroftGUILDFORD, N/A, UNITED KINGDOM - Feb 5, 2020 - Understanding the immune system inChronic Immune-Mediated inflammatory diseases Our immune system is a complex network of cells and organs that together defend the body against harmful foreign invaders such as bacteria and virusesFull story -
Develop high-quality peptidomimetics with Creative Proteomics’ β-Amino Acids Analysis solutions
Feb 4, 2020, 09:15 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Feb 1, 2020 - β-amino acid refers to an amino acid in which an amino group is bonded to a carbon atom at the β positionFull story -
Accurate and affordable Total RNA sequencing provided by CD Genomics
Feb 4, 2020, 09:13 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Feb 1, 2020 - CD Genomics introduced accurate and affordable RNA-seq and Total RNA sequencing. CD genomics combines proven ribosomal reduction library preparation chemistries and Illumina NGS technology into a single, streamlined protocol, which enable researchers to quickly and easily conduct gene expression studies that provide a complete view of the transcriptome, even from low-quality RNA samplesFull story -
MR Solutions helps new ImPaKT facility become the best equipped containment laboratory in Canada
Feb 4, 2020, 06:14 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Feb 4, 2020 - MR Solutions has installed a 3T PET-MR preclinical imaging system at Western Universitys one of a kind ImPaKT Laboratory in OntarioFull story -
New Elsevier report highlights link between the microbiome and melanoma
Feb 4, 2020, 04:56 AM by Michael CroftNEW YORK, NY, UNITED STATES - Feb 4, 2020 - Elsevier, the information analytics company specializing in science and health, has published the findings of a new report on melanoma R&D, created by its Professional Services group, highlighting the implication of the microbiome in the onset and progression of the disease, as well as in the toxicity of, and response rate, to cancer treatmentsFull story -
Accumen’s 3DR Labs Partners with Resonance Health to Expand its MRI Analysis Services
Feb 3, 2020, 11:13 AM by Michael CroftPHOENIX, AZ - Feb 3, 2020 - Accumen Inc., the leader in healthcare performance, announced today that its 3DR Labs, LLC company is partnering with Resonance Health Limited (ASX: RHT) to provide FerriSmart magnetic resonance imaging- (MRI-) based liver iron concentration reports for its clientsFull story -
Will Research In Space Make Science Fiction Come True?
Feb 3, 2020, 06:45 AM by Michael CroftFull storyBio-IT World | Orbital Transports is positioning itself as the purveyor of the services and supplies needed in an emerging space-based economy. The immediate goal is an online marketplace for everything one might need to execute a small satellite mission, including life science companies looking to do disease modeling and conduct pharmaceutical and regenerative medicine research.
-
Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites
Feb 3, 2020, 05:31 AM by Michael CroftSLOUGH/DUNDEE, UK - Feb 3, 2020 - Hypha Discovery Limited, the leading specialist CRO for drug metabolite provision, and Cypex Limited, experts in the provision of recombinant xenobiotic metabolising enzymes, have formed a partnership wherein Hypha can scale-up and purify metabolites made by Cypex enzymes (available as Bactosomes)Full story -
Greenphire and Lazarex Cancer Foundation Unite to Address Strategies for Improving Patient Access and Retention in Cancer Clinical Trials
Jan 31, 2020, 09:14 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Jan 31, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)'s annual Global Oncology Site Solutions SummitFull story